Corien Eeltink

1.2k citations

40 papers · 848 indexed · h-index 17

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
Family Practice top 10%

Papers in ⓘ

Hematology 12
- Acute Myeloid Leukemia Research 6
- Multiple Myeloma Research and Treatments 6
- Hematopoietic Stem Cell Transplantation 5
Family Practice 2

Co-authors: Irma M. Verdonck‐de Leeuw (12 shared papers)Arjan A. van de Loosdrecht (7 shared papers)Jan B. Vermorken (4 shared papers)Theresia M. Westers (5 shared papers)Otto Visser (5 shared papers)Gert J. Ossenkoppele (5 shared papers)J. B. Vermorken (2 shared papers)J.G. Wolbers (1 shared paper)
Journals: Blood (5 papers)Supportive Care in Cancer (4 papers)Bone Marrow Transplantation (3 papers)BMC Cancer (2 papers)European Journal of Cancer (2 papers)
Partner nations: Netherlands Italy United Kingdom

In The Last Decade

Corien Eeltink

37 papers receiving 830 citations

Peers

Countries citing papers authored by Corien Eeltink

Since Specialization

Citations

This map shows the geographic impact of Corien Eeltink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corien Eeltink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corien Eeltink more than expected).

Fields of papers citing papers by Corien Eeltink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corien Eeltink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corien Eeltink. The network helps show where Corien Eeltink may publish in the future.

Co-authors

The 25 scholars most cited alongside Corien Eeltink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Corien Eeltink Line = papers co-authored together Corien Eeltink links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Paclitaxel (TAXOL®) concentrations in brain tumor tissue Annals of Oncology ·J.J. Heimans, J. B. Vermorken, J.G. Wolbers, Corien Eeltink, Otto W.M. Meijer, (unknown), J. H. Beijnen	1994	102
2	A dose-finding and pharmacokinetic study of reversal of multidrug resistance with SDZ PSC 833 in combination with doxorubicin in patients with solid tumors. Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) ·Giuseppe Giaccone, Sabine C. Linn, Jan Welink, G. Catimel, Hans Stieltjes, W. J. F. van der Vijgh, Corien Eeltink, Jan B. Vermorken, Herbert M. Pinedo	1997	71
3	A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia Cancer Immunology Immunotherapy ·Arjan A. van de Loosdrecht, Sandra van Wetering, Saskia J. Santegoets, Satwinder Singh, Corien Eeltink, Yvonne den Hartog, Malika Koppes, Jorn Kaspers, Gert J. Ossenkoppele, Ada M. Kruisbeek, Tanja D. de Gruijl	2018	71
4	Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment Blood ·Theresia M. Westers, Canan Alhan, Martine E.D. Chamuleau, Maurice J. D. L. van der Vorst, Corien Eeltink, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht	2009	61
5	Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome Haematologica ·Martine E.D. Chamuleau, Theresia M. Westers, L. van Dreunen, J. Groenland, Adri Zevenbergen, Corien Eeltink, G. J. Ossenkoppele, Arjan A. van de Loosdrecht	2009	50
6	Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation BMC Cancer ·Linda Bouwman, Corien Eeltink, Otto Visser, Jeroen J. W. M. Janssen, Jolanda Maaskant	2017	48
7	Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice Supportive Care in Cancer ·Antoinetta J. M. Beijers, Gerard Vreugdenhil, Simone Oerlemans, M. Eurelings, Monique C. Minnema, Corien Eeltink, Lonneke V. van de Poll‐Franse, Floortje Mols	2015	45
8	Pharmacokinetics of amifostine and its metabolites in patients European Journal of Cancer ·A.E.C. Korst, Corien Eeltink, Jan B. Vermorken, W.J.F. van der Vijgh	1997	44
9	The efficacy of Life Review Therapy combined with Memory Specificity Training (LRT-MST) targeting cancer patients in palliative care: A randomized controlled trial PLoS ONE ·Gitta Kleijn, Birgit I. Lissenberg‐Witte, Ernst T. Bohlmeijer, Bas Steunenberg, Kitty Knipscheer-Kuijpers, Vincent Willemsen, Annemarie Becker‐Commissaris, Egbert F. Smit, Corien Eeltink, A. Bruynzeel, Maurice Van Der Vorst, Remco de Bree, C. René Leemans, Michiel W. M. van den Brekel, Pim Cuijpers, Irma M. Verdonck‐de Leeuw	2018	33
10	Maternal haemolysis, elevated liver enzymes and low platelets syndrome: Specific problems in the newborn European Journal of Pediatrics ·Corien Eeltink, Richard A. van Lingen, J. G. Aarnoudse, Jan Derks, A Okken	1993	33
11	Self-management support and eHealth for patients and informal caregivers confronted with advanced cancer: an online focus group study among nurses BMC Palliative Care ·Vina N. Slev, H. Roeline W. Pasman, Corien Eeltink, Cornelia F. van Uden–Kraan, Irma M. Verdonck‐de Leeuw, Anneke L. Francke	2017	31
12	Perceived need for information of patients with haematological malignancies: a literature review Journal of Clinical Nursing ·Janneke A. J. Rood, Corien Eeltink, F.J. van Zuuren, Irma M. Verdonck‐de Leeuw, Peter C. Huijgens	2014	30
13	Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes Cytometry Part B Clinical Cytometry ·Canan Alhan, Theresia M. Westers, Lieke H. van der Helm, Corien Eeltink, Gerwin Huls, Birgit I. Lissenberg‐Witte, Francesca Buchi, Valeria Santini, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht	2014	24
14	Distress and quality of life after autologous stem cell transplantation: a randomized clinical trial to evaluate the outcome of a web-based stepped care intervention BMC Cancer ·Annemarie Braamse, Berno van Meijel, Otto Visser, Patricia van Oppen, Annette D. Boenink, Corien Eeltink, Pim Cuijpers, Peter C. Huijgens, Aartjan T.F. Beekman, Joost Dekker	2010	22
15	Fertility and sexual function in female Hodgkin lymphoma survivors of reproductive age Journal of Clinical Nursing ·Corien Eeltink, Luca Incrocci, Birgit I. Lissenberg‐Witte, Saskia Meurs, Otto Visser, Peter C. Huijgens, Irma M. Verdonck‐de Leeuw	2013	21
16	Efficacy of the eHealth application Oncokompas, facilitating incurably ill cancer patients to self-manage their palliative care needs: A randomized controlled trial The Lancet Regional Health - Europe ·Anouk S. Schuit, Karen Holtmaat, Birgit I. Lissenberg‐Witte, Simone E. J. Eerenstein, Josée M. Zijlstra, Corien Eeltink, Annemarie Becker‐Commissaris, Lia van Zuylen, Myra E. van Linde, C. Willemien Menke‐van der Houven van Oordt, Dirkje W. Sommeijer, Nol Verbeek, Koop Bosscha, Rishi Nandoe Tewarie, Robert-Jan Sedee, Remco de Bree, Alexander de Graeff, Filip De Vos, Pim Cuijpers, Irma M. Verdonck‐de Leeuw	2022	17
17	Analysis of Efficacy and Prognostic Factors of Lenalidomide Treatment as Part of a Dutch Compassionate Use Program Clinical Lymphoma Myeloma & Leukemia ·Evelien Kneppers, Henk M. Lokhorst, Corien Eeltink, Gerwin Huls, Marie José Kersten, Jan Koedam, Monique C. Minnema, Marinus H. J. van Oers, Reinier Raymakers, M. Ronald Schaafsma, Edo Vellenga, Pierre W. Wijermans, Shulamiet Wittebol, Pieter Sonneveld, Sonja Zweegman	2010	16
18	Health-care professionals’ perspective on discussing sexual issues in adult patients after haematopoietic cell transplantation Bone Marrow Transplantation ·Corien Eeltink, Birgit I. Lissenberg‐Witte, Jacqui Stringer, Sarah Liptrott, Aleksandra Babić, David Greenfield, Nina Salooja, Luca Incrocci, Otto Visser, Irma M. Verdonck‐de Leeuw, Rafael F. Duarte, Sonja Zweegman	2017	14
19	Pharmacokinetics of carboplatin with and without amifostine in patients with solid tumors. PubMed ·A.E.C. Korst, M L van der Sterre, Corien Eeltink, Anne Marie J. Fichtinger-Schepman, Jan B. Vermorken, W J van der Vijgh	1997	14
20	Self-Reported Sexual Function in Sexually Active Male Hodgkin Lymphoma Survivors Sexual Medicine ·Corien Eeltink, Birgit I. Lissenberg‐Witte, Luca Incrocci, Annemarie Braamse, Otto Visser, Josée M. Zijlstra, Irma M. Verdonck‐de Leeuw, Sonja Zweegman	2020	13

About Corien Eeltink

Corien Eeltink is a scholar working on Hematology, Family Practice, Issues, ethics and legal aspects, Oncology and Psychiatry and Mental health, having authored 40 papers that have together received 848 indexed citations. Recurring topics across this work include Cancer survivorship and care (11 papers), Childhood Cancer Survivors' Quality of Life (8 papers), Sexual function and dysfunction studies (7 papers), Acute Myeloid Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Cancer Treatment and Pharmacology (4 papers) and LGBTQ Health, Identity, and Policy (4 papers). The work is most often cited by research in Hematology (243 citations), Family Practice (32 citations), Oncology (376 citations), Genetics (123 citations) and Pediatrics, Perinatology and Child Health (149 citations). Corien Eeltink has collaborated with scholars based in Netherlands, Italy and United Kingdom. Frequent co-authors include Irma M. Verdonck‐de Leeuw, Arjan A. van de Loosdrecht, Jan B. Vermorken, Theresia M. Westers, Otto Visser, Gert J. Ossenkoppele, J. B. Vermorken, J.G. Wolbers, J. H. Beijnen and Otto W.M. Meijer. Their work appears in journals such as Blood, Supportive Care in Cancer, Bone Marrow Transplantation, BMC Cancer and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact